Liposcience, Inc. IPO Advisory
Share this IPO Profile:
Smart Search
Company |
Symbol |
Price Range |
Issue Price |
Open |
Shares |
Trade Date |
Liposcience, Inc. | LPDX - NASDAQ |
$13.00-$15.00 |
$9.00 |
$9.75 | 5 million | 1/25/2013 |
Barclays Capital, UBS Investment Bank, Piper Jaffray |
Co-Manager(s): |
Health Care |
Filing(s): |
For IPO Boutique's "scale of 1 to 5" BUY rating on Liposcience, Inc., and our comprehensive analysis, click "Buy Market Research".
Liposcience, Inc. Quote & Chart - Click for current quote -
LPDX
About Liposcience, Inc. (adapted from Liposcience, Inc. prospectus):
They are an in vitro diagnostic company committed to advancing patient care in cardiovascular, metabolic and other diseases using our innovative and proprietary technology platform based on nuclear magnetic resonance, or NMR.
This description is adapted from Liposcience prospectus. This description is not intended to be a recommendation to buy stock from this company. To see the company's full description, view their prospectus.
IPO Boutique aggregates information on public companies and private companies, such as Liposcience "LPDX" IPO, which is intended to educate our readers and help them evaluate potential investment opportunities and market conditions. We endeavor to research the financial industry and obtain independent verification of factual statements before presenting them to our users. Be informed.
© 2005 - 2024 IPO Boutique. All Rights Reserved